Niacin 100 mg Nicotinic Acid
60/100
Review before taking
- Niacin: 100mg is 2.9× the Tolerable Upper Intake Level (35mg)
- 100% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Niacin: 100mg is 2.9× the Tolerable Upper Intake Level (35mg)
The safety score is low because the 100mg dose of niacin is nearly three times higher than the recommended maximum daily limit of 35mg.
Label Data
1 Tablet(s)
Serving Size
250
Servings
Vitamin
Product Type
100%
Evidence Coverage
Supplement Facts — Evidence Check
100 mg
(500% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 2.9× (UL: 35 mg)
📚 193 studies (Tier A: 5, B: 63)
Other Ingredients
Cellulose
Vegetable Stearate
Silica
Label Claims — Verification
❓
All Other
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Dairy Free
Sugar Free
Product Information
📋 Directions for Use
Suggested Usage: As a dietary supplement, adults take 1 tablet daily or as directed by physician.
⚠️ Warnings & Precautions
Tamper resistant package, do not use if outer seal is missing.
KEEP OUT OF REACH OF CHILDREN.
🧪 Formulation Notes
This product contains NO yeast, wheat gluten, soy protein, milk/dairy, corn, sodium, sugar, starch, artificial coloring, preservatives or flavoring.
Additional Information
Formula #7977
For optimal storage conditions, store in a cool, dry place. (59(0)-77(0)F/15(0)-25(0)C) (35-65% relative humidity)
Product Details
UPC / SKU
3 10539 01351 9
DSLD Entry Date
2012-06-25
Product Type
Vitamin
Form
Tablet or Pill
Brand
Douglas Laboratories
DSLD ID
9378
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Rezistaf
LifeLink
100
Coenzymated B-3 25 mg
Source Naturals
100
Vitamin B Complex
Simply Supplements
100
Test X180 Boost
Force Factor
100
8-Hour Alert
MHP Maximum Human Performance
100